Imaging of Inflammation in Unexplained Cardiomyopathy

JACC: Cardiovascular Imaging

Volumn 9, Issue 5, 2016, Pages 603-617

  Kadkhodayan, Ana ^a   Chareonthaitawee, Panithaya ^a   Raman, Subha V ^b   Cooper, Leslie T ^c  

^a MAYO CLINIC   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

cardiac sarcoidosis; eosinophilic myocarditis; giant cell myocarditis; lymphocytic myocarditis; myocarditis imaging

Indexed keywords

ARTICLE; CARDIAC IMAGING; CARDIOMYOPATHY; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; CONTRAST ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EOSINOPHILIC MYOCARDITIS; FUNCTIONAL ASSESSMENT; GIANT CELL; HEART BLOCK; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; LYMPHOCYTIC MYOCARDITIS; MOLECULAR IMAGING; MYOCARDITIS; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRESYNCOPE; PRIORITY JOURNAL; RADIATION EXPOSURE; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN CARDIAC DEATH; TISSUE CHARACTERIZATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; UNEXPLAINED CARDIOMYOPATHY; CARDIOMYOPATHIES; COMPLICATION; DIAGNOSTIC IMAGING; HUMAN; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR;

CARDIAC IMAGING TECHNIQUES; CARDIOMYOPATHIES; HUMANS; MYOCARDITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84965122383     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2016.01.010     Document Type: Review

References (77)

1. B.J. Maron, J.A. Towbin, G. Thiene, and et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
2. A.L.P. Caforio, S. Pankuweit, E. Arbustini, and et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 34 2013 2636 2648 2648a-d
3. G.M. Felker, R.E. Thompson, J.M. Hare, and et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
4. J.W. Mason, J.B. O'Connell, A. Herskowitz, and et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators N Engl J Med 333 1995 269 275
5. R. Wojnicz, E. Nowalany-Kozielska, C. Wojciechowska, and et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results Circulation 104 2001 39 45
6. R. Tung, B. Bauer, H. Schelbert, and et al. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis Heart Rhythm 12 2015 2488 2498
7. L.T. Cooper, K.L. Baughman, A.M. Feldman, and et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation 116 2007 2216 2233
8. K.L. Baughman Diagnosis of myocarditis: death of Dallas criteria Circulation 113 2006 593 595
9. R.C. Shields, H.D. Tazelaar, G.J. Berry, and L.T. Cooper The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis J Card Fail 8 2002 74 78
10. R. Kandolin, J. Lehtonen, K. Salmenkivi, A. Räisänen-Sokolowski, J. Lommi, and M. Kupari Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression Circ Heart Fail 6 2013 15 22
11. L.A. Blauwet, and L.T. Cooper Idiopathic giant cell myocarditis and cardiac sarcoidosis Heart Fail Rev 18 2013 733 746
12. I. Kindermann, C. Barth, F. Mahfoud, and et al. Update on myocarditis J Am Coll Cardiol 59 2012 779 792
13. M.G. Friedrich, U. Sechtem, J. Schulz-Menger, and et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper J Am Coll Cardiol 53 2009 1475 1487
14. M. Francone, C. Chimenti, N. Galea, and et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis J Am Coll Cardiol Img 7 2014 254 263
15. H. Mahrholdt, A. Wagner, C.C. Deluigi, and et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis Circulation 114 2006 1581 1590
16. V.M. Ferreira, S.K. Piechnik, E. Dall'Armellina, and et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging J Am Coll Cardiol Img 6 2013 1048 1058
17. R. Hinojar, L. Foote, E. Arroyo Ucar, and et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR J Am Coll Cardiol Img 8 2015 37 46
18. T. Rogers, M.-L. Yap, and V.O. Puntmann Myocardial T1 mapping: a non-invasive alternative to tissue diagnosis? Eur Heart J Cardiovasc Imaging 16 2015 108 109
19. S.K. Piechnik, V.M. Ferreira, A.J. Lewandowski, and et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI J Cardiovasc Magn Reson 15 2013 13
20. D.H. Birnie, W.H. Sauer, F. Bogun, and et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis Heart Rhythm 11 2014 1305 1323
21. D. Fairweather, T.R. Guilarte, and L.T. Cooper Biomarker and more: can translocator protein 18 kDa predict recovery from brain injury and myocarditis? Biomark Med 8 2014 605 607
22. H.N. Skouri, G.W. Dec, M.G. Friedrich, and L.T. Cooper Noninvasive imaging in myocarditis J Am Coll Cardiol 48 2006 2085 2093
23. R.B. van Heeswijk, J. De Blois, G. Kania, and et al. Selective in vivo visualization of immune-cell infiltration in a mouse model of autoimmune myocarditis by fluorine-19 cardiac magnetic resonance Circ Cardiovasc Imaging 6 2013 277 284
24. L.T. Cooper, and D. Fairweather We see only what we look for: imaging cardiac inflammation Circ Cardiovasc Imaging 6 2013 165 166
25. F.S. Villanueva Molecular imaging of cardiovascular disease using ultrasound J Nucl Cardiol 15 2008 576 586
26. J.-F. Hsiao, Y. Koshino, C.R. Bonnichsen, and et al. Speckle tracking echocardiography in acute myocarditis Int J Cardiovasc Imaging 29 2013 275 284
27. G. Di Bella, S. Coglitore, C. Zimbalatti, and et al. Strain Doppler echocardiography can identify longitudinal myocardial dysfunction derived from edema in acute myocarditis Int J Cardiol 126 2008 279 280
28. J.A. White, M. Rajchl, J. Butler, R.T. Thompson, F.S. Prato, and G. Wisenberg Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography - magnetic resonance imaging for the diagnosis of cardiac disease Circulation 127 2013 e639 e641
29. M.R. Stacy, M.W. Maxfield, and A.J. Sinusas Targeted molecular imaging of angiogenesis in PET and SPECT: a review Yale J Biol Med 85 2012 75 86
30. M.C. Iannuzzi, B.A. Rybicki, and A.S. Teirstein Sarcoidosis N Engl J Med 357 2007 2153 2165
31. N.R. Aggarwal, D. Snipelisky, P.M. Young, B.J. Gersh, L.T. Cooper, and P. Chareonthaitawee Advances in imaging for diagnosis and management of cardiac sarcoidosis Eur Heart J Cardiovasc Imaging 16 2015 949 958
32. L.S. Newman, C.S. Rose, and L.A. Maier Sarcoidosis N Engl J Med 336 1997 1224 1234
33. R. Kandolin, J. Lehtonen, J. Airaksinen, and et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study Circulation 131 2015 624 632
34. M.A. Judson, R.P. Baughman, A.S. Teirstein, M.L. Terrin, and H. Yeager Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 16 1999 75 86
35. Y. Yazaki, M. Isobe, M. Hiroe, and et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone Am J Cardiol 88 2001 1006 1010
36. D. Mehta, S.A. Lubitz, Z. Frankel, and et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing Chest 133 2008 1426 1435
37. E. Joyce, M.K. Ninaber, S. Katsanos, and et al. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis Eur J Heart Fail 17 2015 51 62
38. R. Langah, K. Spicer, M. Gebregziabher, and L. Gordon Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis J Nucl Cardiol 16 2009 801 810
39. H. Yamagishi, N. Shirai, M. Takagi, and et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET J Nucl Med 44 2003 1030 1036
40. S. Ishimaru, I. Tsujino, T. Takei, and et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis Eur Heart J 26 2005 1538 1543
41. G. Youssef, E. Leung, I. Mylonas, and et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2012 241 248
42. H. Ohira, I. Tsujino, S. Ishimaru, and et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis Eur J Nucl Med Mol Imaging 35 2008 933 941
43. H. Skali, A.R. Schulman, and S. Dorbala 18F-FDG PET/CT for the assessment of myocardial sarcoidosis Curr Cardiol Rep 15 2013 352
44. R. Blankstein, M. Osborne, M. Naya, and et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis J Am Coll Cardiol 63 2014 329 336
45. O. Manabe, K. Yoshinaga, H. Ohira, and et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis J Nucl Cardiol 23 2016 244 252
46. M. Morooka, M. Moroi, K. Uno, and et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis EJNMMI Res 4 2014 1
47. J.P. Bois, and P. Chareonthaitawee Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis J Nucl Cardiol 23 2016 253 255
48. N. Tahara, A. Tahara, Y. Nitta, and et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis J Am Coll Cardiol Img 3 2010 1219 1228
49. A. Ahmadian, A. Brogan, J. Berman, and et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis J Nucl Cardiol 21 2014 925 939
50. 18F- fluorodoexyglucose positron emission tomography? Circ Cardiovasc Imaging 6 2013 617 626
51. Y. Ishida, K. Yoshinaga, M. Miyagawa, and et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology Recommendations Ann Nucl Med 28 2014 393 403
52. M. Orii, T. Imanishi, and T. Akasaka Assessment of cardiac sarcoidosis with advanced imaging modalities BioMed Res Int 2014 2014 897956
53. J.-P. Smedema, G. Snoep, M.P.G. van Kroonenburgh, and et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690
54. F. Matoh, H. Satoh, K. Shiraki, and et al. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis J Cardiol 51 2008 179 188
55. M.R. Patel, P.J. Cawley, J.F. Heitner, and et al. Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
56. S. Greulich, C.C. Deluigi, S. Gloekler, and et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis J Am Coll Cardiol Img 6 2013 501 511
57. E.D. Crouser, C. Ono, T. Tran, X. He, and S.V. Raman Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping Am J Respir Crit Care Med 189 2014 109 112
58. H. Bogabathina, P. Olson, V.K. Rathi, and R.W.W. Biederman Cardiac sarcoidosis or giant cell myocarditis? On treatment improvement of fulminant myocarditis as demonstrated by cardiovascular magnetic resonance imaging Case Rep Cardiol 2012 2012 647041
59. L.T. Cooper Jr., G.J. Berry, and R. Shabetai Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators N Engl J Med 336 1997 1860 1866
60. B.T. Larsen, J.J. Maleszewski, W.D. Edwards, and et al. Atrial giant cell myocarditis: a distinctive clinicopathologic entity Circulation 127 2013 39 47
61. Y. Sujino, F. Kimura, J. Tanno, and et al. Cardiac magnetic resonance imaging in giant cell myocarditis: intriguing associations with clinical and pathological features Circulation 129 2014 e467 e469
62. A. Azarine, R. Guillemain, and P. Bruneval Different focal delayed gadolinium-enhancement patterns using cardiac magnetic resonance in a case of diffuse giant cell myocarditis Eur Heart J 30 2009 1485
63. A.M. Al Ali, L.P. Straatman, M.F. Allard, and A.P. Ignaszewski Eosinophilic myocarditis: case series and review of literature Can J Cardiol 22 2006 1233 1237
64. F. Ginsberg, and J.E. Parrillo Eosinophilic myocarditis Heart Fail Clin 1 2005 419 429
65. H. Tani, Y. Amano, M. Tachi, T. Machida, K. Mizuno, and S. Kumita T2-weighted and delayed enhancement MRI of eosinophilic myocarditis: relationship with clinical phases and global cardiac function Jpn J Radiol 30 2012 824 831
66. S. Baumann, C.N. De Cecco, U.J. Schoepf, and et al. Correlation of cardiac magentic resonance imaging and histopathology in eosinophilic endomyocarditis Circ Cardiovasc Imaging 8 2015 e002501
67. E.Y. Kim, S.-A. Chang, Y.-K. Lee, J.-O. Choi, and Y.H. Choe Early non-invasive diagnosis and treatment of acute eosinophilic myopericarditis by cardiac magnetic resonance J Korean Med Sci 26 2011 1522 1526
68. M. Kimura, T. Kato, T. Izumi, and M. Inoko Sequential cardiac magnetic resonance imaging of acute eosinophilic myocarditis Intern Med Tokyo Jpn 52 2013 2285 2286
69. K. Debl, B. Djavidani, S. Buchner, and et al. Time course of eosinophilic myocarditis visualized by CMR J Cardiovasc Magn Reson 10 2008 21
70. R. Shah, and K. Ananthasubramaniam Evaluation of cardiac involvement in hypereosinophilic syndrome: complementary roles of transthoracic, transesophageal, and contrast echocardiography Echocardiogr Mt Kisco N 23 2006 689 691
71. J.W. Weinsaft, R.J. Kim, M. Ross, and et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus J Am Coll Cardiol Img 2 2009 969 979
72. G. Friman, L. Wesslén, J. Fohlman, J. Karjalainen, and C. Rolf The epidemiology of infectious myocarditis, lymphocytic myocarditis and dilated cardiomyopathy Eur Heart J 16 Suppl O 1995 36 41
73. R. Davidoff, I. Palacios, J. Southern, J.T. Fallon, J. Newell, and G.W. Dec Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes Circulation 83 1991 953 961
74. A.L.P. Caforio, F. Tona, A. Vinci, and et al. Acute biopsy-proven lymphocytic myocarditis mimicking Takotsubo cardiomyopathy Eur J Heart Fail 11 2009 428 431
75. S. Hiramitsu, S. Morimoto, S. Kato, and et al. Significance of transient left ventricular wall thickening in acute lymphocytic myocarditis Heart Vessels 22 2007 25 29
76. K.B. James, K. Lee, J.D. Thomas, and et al. Left ventricular diastolic dysfunction in lymphocytic myocarditis as assessed by Doppler echocardiography Am J Cardiol 73 1994 282 285
77. T.S. Nielsen, J.R. Nyengaard, J. Møller, J. Banner, L.P. Nielsen, and U.T. Baandrup Quantitative diagnosis of lymphocytic myocarditis in forensic medicine Forensic Sci Int 238 2014 9 15